Ikuo Hirano
#149,929
Most Influential Person Now
Researcher
Ikuo Hirano's AcademicInfluence.com Rankings
Ikuo Hiranocomputer-science Degrees
Computer Science
#7808
World Rank
#8215
Historical Rank
Computational Linguistics
#1640
World Rank
#1657
Historical Rank
Machine Learning
#3019
World Rank
#3056
Historical Rank
Artificial Intelligence
#3314
World Rank
#3363
Historical Rank
Download Badge
Computer Science
Ikuo Hirano's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Ikuo Hirano Influential?
(Suggest an Edit or Addition)Ikuo Hirano's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Eosinophilic esophagitis: updated consensus recommendations for children and adults. (2011) (1878)
- ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE) (2013) (996)
- Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system (2012) (589)
- Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. (2018) (561)
- Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. (2012) (547)
- Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. (2006) (438)
- Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial (2011) (412)
- ACG Practice Guidelines: Esophageal Reflux Testing (2007) (359)
- Epidemiology and Natural History of Eosinophilic Esophagitis. (2017) (351)
- Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylase mutations (2000) (318)
- Mechanical properties of the esophagus in eosinophilic esophagitis. (2011) (298)
- Esophageal Dilation in Eosinophilic Esophagitis: Effectiveness, Safety, and Impact on the Underlying Inflammation (2010) (269)
- Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis (2015) (265)
- Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. (2015) (247)
- American Gastroenterological Association Institute Guideline on the Management of Acute Diverticulitis. (2015) (235)
- Pediatric and adult eosinophilic esophagitis: similarities and differences (2012) (229)
- Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. (2013) (227)
- Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. (2019) (222)
- Conjunctivitis in dupilumab clinical trials (2019) (220)
- Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis. (2016) (217)
- Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). (2010) (215)
- Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis. (2014) (198)
- Histopathologic Variability in Children With Eosinophilic Esophagitis (2009) (172)
- Manometric heterogeneity in patients with idiopathic achalasia. (2001) (160)
- Evaluation of Esophageal Motility Utilizing the Functional Lumen Imaging Probe (2016) (158)
- Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis. (2017) (158)
- Functional Lumen Imaging Probe for the Management of Esophageal Disorders: Expert Review From the Clinical Practice Updates Committee of the AGA Institute (2017) (149)
- Plasticity of renal erythropoietin-producing cells governs fibrosis. (2013) (141)
- RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis. (2019) (141)
- Esophageal Microbiome in Eosinophilic Esophagitis (2015) (134)
- American Gastroenterological Association Institute Guideline on the Management of Crohn's Disease After Surgical Resection. (2017) (134)
- Manometric features of eosinophilic esophagitis in esophageal pressure topography (2011) (127)
- Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling. (2016) (123)
- Esophagogastric junction distensibility measurements during Heller myotomy and POEM for achalasia predict postoperative symptomatic outcomes (2014) (116)
- Symptomatic and physiologic outcomes one year after peroral esophageal myotomy (POEM) for treatment of achalasia (2014) (111)
- T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis. (2014) (110)
- Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. (2014) (104)
- Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis. (2020) (104)
- Development and field testing of a novel patient‐reported outcome measure of dysphagia in patients with eosinophilic esophagitis (2013) (102)
- The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health‐related quality of life (2011) (101)
- AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis. (2020) (100)
- Isolation and Characterization of Renal Erythropoietin-Producing Cells from Genetically Produced Anemia Mice (2011) (95)
- EUS and histopathologic correlates in eosinophilic esophagitis. (2001) (92)
- Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study. (2018) (90)
- Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009. (2012) (89)
- Esophagogastric Junction Morphology Predicts Susceptibility to Exercise-Induced Reflux (2004) (86)
- Nrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers (2013) (81)
- Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. (2005) (79)
- Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity (2015) (69)
- Functional luminal imaging probe topography: an improved method for characterizing esophageal distensibility in eosinophilic esophagitis (2013) (69)
- Effectiveness of esophageal dilation for symptomatic cricopharyngeal bar. (2005) (68)
- Late‐onset MNGIE due to partial loss of thymidine phosphorylase activity (2005) (65)
- Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis (2016) (65)
- A mouse model of adult-onset anaemia due to erythropoietin deficiency (2013) (64)
- Eosinophilic Esophagitis Reference Score Accurately Identifies Disease Activity and Treatment Effects in Children (2017) (63)
- Expression of mast cell-associated genes is upregulated in adult eosinophilic esophagitis and responds to steroid or dietary therapy. (2011) (62)
- Qualitative Assessment of Patient-reported Outcomes in Adults With Eosinophilic Esophagitis (2011) (62)
- Improvement in Esophageal Distensibility in Response to Medical and Diet Therapy in Eosinophilic Esophagitis (2017) (59)
- Achalasia treatment: improved outcome of laparoscopic myotomy with operative manometry. (2004) (58)
- Practical approach to implementing dietary therapy in adults with eosinophilic esophagitis: the Chicago experience. (2015) (56)
- Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies (2015) (55)
- Proton pump inhibitor-responsive esophageal eosinophilia does not preclude food-responsive eosinophilic esophagitis. (2016) (54)
- Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference. (2018) (54)
- AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis. (2020) (53)
- Assessing Adherence and Barriers to Long-Term Elimination Diet Therapy in Adults with Eosinophilic Esophagitis (2018) (52)
- Therapeutic end points in eosinophilic esophagitis: is elimination of esophageal eosinophils enough? (2012) (51)
- Pathophysiology of achalasia (1999) (50)
- Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes (2015) (47)
- Review article: modern technology in the diagnosis of gastro‐oesophageal reflux disease – Bilitec, intraluminal impedance and Bravo capsule pH monitoring (2006) (46)
- Evaluation of esophageal distensibility in eosinophilic esophagitis: an update and comparison of functional lumen imaging probe analytic methods (2016) (46)
- Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis. (2012) (43)
- How Do Gastroenterologists Assess Overall Activity of Eosinophilic Esophagitis in Adult Patients? (2015) (42)
- 727 A Prospective Clinical Trial of Six Food Elimination Diet and Reintroduction of Causative Agents in Adults with Eosinophilic Esophagitis (EE) (2008) (42)
- Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures (2015) (41)
- Dilation in eosinophilic esophagitis: to do or not to do? (2010) (41)
- Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis (2019) (41)
- The Chicago Classification of Esophageal Motility Disorders , v 3 . 0 International High Resolution Manometry Working Group (2015) (39)
- Alignment of parent‐ and child‐reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites (2018) (38)
- Erythropoietin production in neuroepithelial and neural crest cells during primitive erythropoiesis (2013) (38)
- One-Hour Esophageal String Test: A Nonendoscopic Minimally Invasive Test That Accurately Detects Disease Activity in Eosinophilic Esophagitis (2019) (37)
- Eosinophilic esophagitis and gastroesophageal reflux disease: there and back again. (2011) (36)
- Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis. (2019) (36)
- Editorial: Should Patients With Suspected Eosinophilic Esophagitis Undergo a Therapeutic Trial of Proton Pump Inhibition? (2013) (35)
- Should wheat, barley, rye, and/or gluten be avoided in a 6-food elimination diet? (2016) (34)
- Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis (2019) (33)
- Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis—a Systematic Review and Meta-analysis (2019) (33)
- Biological therapies for eosinophilic gastrointestinal diseases (2018) (32)
- EMERGING THERAPIES FOR EOSINOPHILIC ESOPHAGITIS. (2019) (30)
- White Paper AGA: Drug Development for Eosinophilic Esophagitis (2017) (29)
- Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders (2019) (29)
- Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis. (2020) (29)
- Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial. (2021) (28)
- Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review (2018) (28)
- Acid Reflux Detection and Symptom-Reflux Association Using 4-Day Wireless pH Recording Combining 48-Hour Periods Off and On PPI Therapy (2008) (28)
- S1861 A Prospective Clinical Trial of Six Food Elimination Diet or Elemental Diet in the Treatment of Adults with Eosinophilic Gastroenteritis (2009) (27)
- Deaths after living related liver transplantation (2000) (27)
- Deglutitive inhibition affects both esophageal peristaltic amplitude and shortening. (2003) (26)
- Molecular, Endoscopic, Histologic and Circulating Biomarker-Based Diagnosis of Eosinophilic Gastritis: Multi-Site Study. (2019) (26)
- Creating a multi-center rare disease consortium – the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) (2017) (26)
- 877 Prospective Trial of Four Food Elimination Diet Demonstrates Comparable Effectiveness in the Treatment of Adult and Pediatric Eosinophilic Esophagitis (2013) (25)
- Diagnosis and Treatment of Eosinophilic Esophagitis in Adults. (2016) (24)
- Nrf2 contributes to the weight gain of mice during space travel (2020) (24)
- Advances in diagnostic testing for gastroesophageal reflux disease. (2010) (24)
- Diversion Colitis in Patients with Myelopathy: Clinical, Endoscopic, and Histopathological Findings (2000) (24)
- Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration. (2019) (23)
- Diminished mechanosensitivity and chemosensitivity in patients with achalasia. (2003) (23)
- Therapeutic strategies in eosinophilic esophagitis: Induction, maintenance and refractory disease. (2015) (23)
- Eosinophilic gastrointestinal diseases—clinically diverse and histopathologically confounding (2012) (23)
- Esophageal Hypervigilance and Symptom Specific Anxiety in Patients with Eosinophilic Esophagitis. (2021) (23)
- Prospective assessment of disease-specific quality of life in adults with eosinophilic esophagitis. (2018) (22)
- Long Term Maintenance Therapy With Dietary Restriction in Adults With Eosinophilic Esophagitis (2011) (21)
- Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis (2020) (21)
- Clinical and manometric features of the lower esophageal muscular ring (2000) (20)
- Medical Nutrition Therapy for Patients With Advanced Systemic Sclerosis (MNT PASS): A Pilot Intervention Study (2017) (20)
- An immortalized cell line derived from renal erythropoietin-producing (REP) cells demonstrates their potential to transform into myofibroblasts (2019) (19)
- Renal Anemia Model Mouse Established by Transgenic Rescue with an Erythropoietin Gene Lacking Kidney-Specific Regulatory Elements (2016) (18)
- Role of Advanced Diagnostics for Eosinophilic Esophagitis (2014) (18)
- Chronic Intestinal Pseudo-Obstruction (2000) (18)
- Budesonide Oral Suspension Significantly Improves Eosinophilic Esophagitis Histology Scoring System Results (2019) (18)
- Impact on Health-Related Quality of Life in Adults with Eosinophilic Gastritis and Gastroenteritis: A Qualitative Assessment (2018) (18)
- How to Approach a Patient With Eosinophilic Esophagitis. (2018) (18)
- Eosinophilic esophagitis: Pathophysiology and optimal management (2009) (17)
- Prospective assessment of the diagnostic utility of esophageal brushings in adults with eosinophilic esophagitis. (2016) (17)
- Comparison of endoscopy and radiographic imaging for detection of esophageal inflammation and remodeling in adults with eosinophilic esophagitis. (2017) (17)
- 2015 David Y. Graham Lecture: The First Two Decades Of Eosinophilic Esophagitis—From Acid Reflux To Food Allergy (2016) (17)
- International consensus recommendations for eosinophilic gastrointestinal disease nomenclature. (2022) (17)
- Clinical relevance of esophageal subepithelial activity in eosinophilic esophagitis (2019) (17)
- Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS) (2021) (17)
- An anti-IL-13 antibody reverses epithelial-mesenchymal transition biomarkers in eosinophilic esophagitis: phase 2 trial results. (2020) (16)
- New technologies for the evaluation of esophageal motility disorders: impedance, high-resolution manometry, and intraluminal ultrasound. (2007) (16)
- Application of the Functional Lumen Imaging Probe to Esophageal Disorders (2017) (16)
- Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders. (2016) (14)
- Long-Term Treatment of Eosinophilic Esophagitis with Budesonide Oral Suspension. (2021) (14)
- Diet therapy for eosinophilic esophagitis: when, why and how (2013) (14)
- Emerging drugs for eosinophilic esophagitis (2013) (14)
- Eosinophilic esophagitis: overview of clinical management. (2014) (13)
- Use of a continuing medical education course to improve fellows' knowledge and skills in esophageal disorders. (2011) (13)
- Pathophysiology of achalasia and diffuse esophageal spasm (2006) (13)
- Eosinophilic Esophagitis (EE) in Adults: Emerging Entity or Misdiagnosed Malady (2005) (13)
- Oral delivery of fluticasone powder improves esophageal eosinophilic inflammation and symptoms in adults with eosinophilic esophagitis. (2018) (13)
- Treatment of eosinophilic esophagitis: Drugs, diet, or dilation? (2007) (13)
- Clinical outcomes of adults with eosinophilic esophagitis with severe stricture. (2020) (12)
- Food‐induced immediate response of the esophagus—A newly identified syndrome in patients with eosinophilic esophagitis (2020) (12)
- Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis. (2019) (11)
- Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk. (2021) (11)
- 953 Safety and Efficacy of Oral Budesonide Suspension for Maintenance Therapy in Eosinophilic Esophagitis: Results From a Prospective Open-Label Study of Adolescents and Adults (2016) (10)
- GATA2 hypomorphism induces chronic myelomonocytic leukemia in mice (2019) (10)
- New Developments in the Diagnosis, Therapy, and Monitoring of Eosinophilic Esophagitis (2018) (10)
- New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting. (2018) (10)
- Ambulatory pH Monitoring: New Advances and Indications. (2006) (9)
- Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab. (2021) (9)
- Su1135 Validity, Usability, and Acceptability of the Eosinophilic Esophagitis Quality of Life Scale for Adults (EoE-QOL-A) (2012) (9)
- The Neural Crest as the First Production Site of the Erythroid Growth Factor Erythropoietin (2019) (9)
- Esophageal dysmotility is associated with disease severity in eosinophilic esophagitis. (2021) (9)
- A Randomized, Double-Blind, Placebo-Controlled Trial of a Fluticasone Propionate Orally Disintegrating Tablet in Adult and Adolescent Patients with Eosinophilic Esophagitis: A Phase 1/2A Safety and Tolerability Study (2017) (9)
- Retrograde gastric intussusception after myotomy for achalasia. (2006) (9)
- Endoscopic assessment of eosinophilic esophagitis (2014) (9)
- 350 Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis in Adolescents and Adults: Results From a Phase 3, Randomized, Placebo-Controlled Trial (2019) (9)
- Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial. (2022) (8)
- Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms Following Dilation in Adults with Eosinophilic Esophagitis. (2021) (8)
- EFFeCtiveness AND SAFETY OF High versus low dose swallowed TopICal STEROIDs for Maintenance Treatment of Eosinophilic Esophagitis: A Multi-Center Observational Study. (2020) (8)
- Eosinophilic Esophagitis: Interactions with Gastroesophageal Reflux Disease (2013) (8)
- Type 2 Immunity and Age Modify Gene Expression of Coronavirus-induced Disease 2019 Receptors in Eosinophilic Gastrointestinal Disorders (2020) (8)
- Future Directions in Eosinophilic Esophagitis. (2018) (7)
- Inter-Observer Agreement on Endoscopic Esophageal Findings in Eosinophilic Esophagitis (EoE) (2011) (7)
- Improvements in Dysphagia and Pain With Swallowing in Patients With Eosinophilic Esophagitis Receiving Budesonide Oral Suspension. (2020) (7)
- Evaluating Eosinophilic Colitis as a Unique Disease using Colonic Molecular Profiles: A Multi-Site Study. (2022) (7)
- Conjunctivitis in dupilumab clinical trials (2019) (7)
- High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases (2020) (7)
- A 78-year-old man with difficulty swallowing. (2011) (7)
- Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis. (2022) (7)
- Dupilumab Improves Health-Related Quality of Life (HRQoL) and Reduces Symptom Burden in Patients with Eosinophilic Esophagitis (EoE): Results From Part A of a Randomized, Placebo-Controlled Three-Part Phase 3 Study (2021) (6)
- Bravo pH testing on and off treatment with immediate-release omeprazole: A review of: Effect of PPI therapy on symptom association using four-day Bravo pH recording combining 48-hour periods off and on therapy (2007) (6)
- Eosinophilic esophagitis--emerging epidemic or misdiagnosed malady? (2014) (6)
- AK002, an Anti-Siglec-8 Antibody, Depletes Tissue Eosinophils and Improves Dysphagia Symptoms in Patients with Eosinophilic Esophagitis (2020) (6)
- Dupilumab Improves Clinical and Histologic Aspects of Disease in Adult and Adolescent Patients With Eosinophilic Esophagitis at Week 24: Results from Part B of the 3-Part LIBERTY EoE TREET Study (2022) (6)
- Esophagus: Anatomy and Developmental and Structural Anomalies (2009) (6)
- 813 Oral Budesonide Suspension Significantly Improves Dysphagia and Esophageal Eosinophilia: Results From a Multicenter Randomized Double-Blind Placebo-Controlled Trial in Adolescents and Adults With Eosinophilic Esophagitis (2015) (6)
- Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross‐sectional multi‐center study (2022) (6)
- 888 Quality of Life Assessment in Adults with EoE At Baseline and After Treatment with Dietary Therapy: Is the Treatment Worse Than the Disease? (2009) (6)
- Advances in the endoscopic evaluation of eosinophilic esophagitis (2016) (5)
- Sa1151 - Baseline Characteristics and Correlation Between Dysphagia and Disease Activity in Patients with Eosinophilic Esophagitis in a Randomized, Placebo-Controlled, Phase 2 Dupilumab Trial (2018) (5)
- Responsiveness of a Histologic Scoring System Compared With Peak Eosinophil Count in Eosinophilic Esophagitis (2021) (5)
- Reliability and Responsiveness of Endoscopic Disease Activity Assessment in Eosinophilic Esophagitis. (2022) (5)
- 229 RESULTS FROM THE ELEMENT STUDY: PROSPECTIVE STUDY OF ELEMENTAL DIET IN EOSINOPHILIC GASTROENTERITIS NUTRITION TRIAL (2020) (5)
- Spotlight: Treatment of Eosinophilic Esophagitis (EoE). (2020) (5)
- How I Approach the Management of Eosinophilic Esophagitis in Adults (2017) (5)
- Esophagus: anatomy and structural anomalies (2015) (5)
- Eosinophilic Esophagitis: Etiology and Therapy. (2020) (5)
- Narrow-caliber esophagus of eosinophilic esophagitis: difficult to define, resistant to remedy. (2016) (5)
- 357 – Prospective Evaluation of a Novel, Endoscopic Activity Assessment System for Eosinophilic Gastritis (2019) (5)
- Long‐Term Efficacy and Safety of RPC4046, an Anti‐Interleukin‐13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open‐Label Extension of the HEROES Study: 632 (2019) (5)
- 537 ENDOSCOPY AND SYSTEMATIC BIOPSY OF PATIENTS WITH CHRONIC GASTROINTESTINAL SYMPTOMS LEADS TO HIGH DISCOVERY RATE OF PATIENTS WHO MEET HISTOLOGIC CRITERIA FOR EOSINOPHILIC GASTRITIS AND/OR EOSINOPHILIC DUODENITIS (2021) (4)
- Induction of erythropoietin gene expression in epithelial cells by chemicals identified in GATA inhibitor screenings (2017) (4)
- 598 Eosinophil Derived TGF-ß1 Activates Human Esophageal Mesenchymal Cells and Alters Esophageal Motility - Implications for Dysphagia in Eosinophilic Esophagitis (EoE) (2012) (4)
- 876 - Sustained Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients with Eosinophilic Esophagitis: Results from the Open-Label Extension of the Heroes Study (2018) (4)
- Correlation of the Eosinophilic Histopathological Scoring System with Esophageal Gene Expression in Patients with Eosinophilic Esophagitis (2018) (4)
- 30 ESOPHAGEAL DYSMOTILITY IN EOSINOPHILIC ESOPHAGITIS: ANALYSIS USING HIGH-RESOLUTION ESOPHAGEAL MANOMETRY. (2007) (4)
- Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1–3 clinical trials (2023) (4)
- Author Correction: Nrf2 contributes to the weight gain of mice during space travel (2020) (4)
- Mast cell‐pain connection in eosinophilic esophagitis (2022) (4)
- 1036 A Unique Gene Expression Profile May Predict Responsiveness to Dietary Elimination With Six Food Elimination Diet in Adults With Eosinophilic Esophagitis (2012) (4)
- [A case of toxic shock syndrome]. (1986) (4)
- Development and Validation of Web-Based Tool to Predict Lamina Propria Fibrosis in Eosinophilic Esophagitis (2021) (4)
- Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort (2022) (4)
- Clinical Features at Baseline Cannot Predict Symptom Response to Placebo in Patients With Eosinophilic Esophagitis. (2019) (4)
- Editorial: expanding a narrow perspective on narrow calibre oesophagus in eosinophilic oesophagitis (2015) (3)
- 535 EFFICACY OF ONE-FOOD VERSUS SIX-FOOD ELIMINATION DIET FOR TREATMENT OF EOSINOPHILIC ESOPHAGITIS IN ADULTS: RESULTS FROM THE MULTICENTER RANDOMIZED CONTROLLED SOFEED TRIAL (2021) (3)
- Inhibition of tlesr by atropine reexamined: Primary or secondary effect? (2000) (3)
- T1244 Constructing and Validating a Questionnaire for Dysphagia: the Hospital Odynophagia Dysphagia Questionnaire (HODQ) (2009) (3)
- Impaired esophageal mechanosensitivity and chemosensitivity in achalasia (2001) (3)
- S1088 Duration of Dysphagia is Associated With Increased Frequency of Dysphagia and Food Impaction in Adults With Eosinophilic Esophagitis (2010) (3)
- S1971 Comparison of Demographic, Endoscopic and Histologic Features in EoE Patients with and Without GERD (2008) (3)
- Defining the functionally sufficient regulatory region and liver-specific roles of the erythropoietin gene by transgene complementation. (2021) (3)
- Eosinophilic esophagitis: are we just scratching the surface? (2013) (3)
- S1974 Effectiveness of Oral Budesonide Suspension in Adult Patients with Eosinophilic Esophagitis (2008) (3)
- S1860 Comparison of Endoscopic and Histologic Response in Patients with Eosinophilic Esophagitis Treated with Proton Pump Inhibition, Topical Fluticasone, and Dietary Elimination (2009) (3)
- 113 Randomized, Double-Blind, Placebo Controlled Trial Demonstrates the Efficacy of Oral Budesonide Suspension in Improving Endoscopically Identified Esophageal Abnormalities in Eosinophilic Esophagitis (2015) (3)
- S1875 Epidemiologic Implications of Symptom Onset in Adults with Eosinophilic Esophagitis (2009) (3)
- Long-Term Outcomes of the Six-Food Elimination Diet and Food Reintroduction in a Large Cohort of Adults With Eosinophilic Esophagitis (2022) (3)
- Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference. (2022) (3)
- Changes in Esophageal Distensibility Associated with Treatment Response in Eosinophilic Esophagitis: A Study Utilizing the Functional Lumen Imaging Probe (2017) (3)
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. (2022) (3)
- Low Prevalence of Extraesophageal Gastrointestinal Pathology in Patients with Eosinophilic Esophagitis (2021) (3)
- Modern technology in the diagnosis of gastro-oesophageal reflux disease : Bilitec, intraluminal impedance and Bravo capsule pH monitorinq (2006) (3)
- Editorial: Reflux While Running: Something to Belch About (2016) (2)
- Sa1114 - Efficacy and Safety of Rpc4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients with Active Eosinophilic Esophagitis: Analysis of the Steroid-Refractory Subgroup from the Heroes Study (2018) (2)
- Sa1118 - Eosinophilic Esophagitis-Like Disease with Lack of Significant Esophageal Eosinophilia: Description of a New Disease Entity (2018) (2)
- Clinical Features at Baseline are Not Clearly Associated with Symptomatic Placebo Response in Adolescents and Adults with Eosinophilic Esophagitis During a Placebo Run-in Period of a Double-Blind, Randomized, Controlled Trial of Budesonide Oral Suspension (2017) (2)
- Oral Fluticasone Powder Improves Histopathology in Adults With Eosinophilic Esophagitis: 1706 (2015) (2)
- Su1862 Systematic, Endoscopic Assessment Demonstrates Increased Fibrostenotic and Decreased Inflammatory Esophageal Features in Adults Compared With Children With Eosinophilic Esophagitis (2013) (2)
- Sa1113 - Correlation Between Esophageal Distensibility and Objective Measures of Disease in Patients with Active Eosinophilic Esophagitis: A Post HOC Analysis of a Randomized, Placebo-Controlled, Phase 2 Dupilumab Trial (2018) (2)
- Histopathologic Variability and Clinical Findings in Children with Eosinophilic Esophagitis (2007) (2)
- Management of eosinophilic esophagitis associated food impaction in Europe and the United States. (2022) (2)
- Editorial: oesophageal dilation in eosinophilic oesophagitis—can and should, but when and how? (2017) (2)
- One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. (2023) (2)
- Dupilumab safety and efficacy up to 52 weeks in adult and adolescent patients with eosinophilic esophagitis: Results from part A and C of a randomized, placebo-controlled, three-part, phase 3 LIBERTY EoE TREET Study (2022) (2)
- 92 Increased Esophagogastric Junction Distensibility in GERD Patients Assessed with the Endoscopically Placed Functional Luminal Imaging Probe (Endoflip (2009) (2)
- 932 HISTOLOGIC AND SYMPTOMATIC IMPROVEMENT ACROSS MULTIPLE FORMS OF EOSINOPHILIC GASTROINTESTINAL DISEASES IN ENIGMA, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ANTOLIMAB (AK002) (2020) (2)
- Treatment of Eosinophilic Esophagitis (2010) (2)
- The 1‐Hour Esophageal String Test: A Non‐Endoscopic Minimally Invasive Test to Accurately Detect Disease Activity in Eosinophilic Esophagitis: 935 (2019) (2)
- A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. (2022) (2)
- S1081 Patient Reported Outcomes in Adults With Eosinophilic Esophagitis (2010) (2)
- Letters to the editorDeaths after living related liver transplantation (2000) (2)
- Dupilumab Reduces Biomarkers of Type 2 Inflammation in Adult and Adolescent Patients With Eosinophilic Esophagitis: Results From Parts A and C of a Three-Part, Phase 3 LIBERTY EoE TREET Study (2022) (2)
- S1094 Limited Accuracy of Upper GI Studies in the Diagnosis of Eosinophilic Esophagitis in Adults (2010) (2)
- 539 LONG-TERM TREATMENT OF PATIENTS WITH EOSINOPHILIC GASTRITIS AND/OR EOSINOPHILIC DUODENITIS WITH LIRENTELIMAB, A MONOCLONAL ANTIBODY AGAINST SIGLEC-8 (2021) (1)
- 361 – Functional Luminal Imaging Probe Provides an Accurate Assessment of Esophageal Diameter in Patients with Eosinophilic Esophagitis Undergoing Dilation (2019) (1)
- Differentiation of GERD From Eosinophilic Esophagitis (EoE): Predictive Factors and Response to PPI Trial (2011) (1)
- Endoscopic diagnosis and treatment of disorders of upper esophageal sphincter function (2018) (1)
- S0345 Safety and Efficacy of Long-Term Treatment of EoE With Fluticasone Propionate Orally Disintegrating Tablet (APT-1011): Results From 40 Weeks Treatment in a Phase 2b Randomized Double-Blind Placebo-Controlled Trial (2020) (1)
- Mo1183 PREDICTORS OF RESPONSE TO CORTICOSTEROID THERAPY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION (2020) (1)
- Editorial: long‐term effectiveness of elimination diet therapy for eosinophilic oesophagitis—is the glass half full or half empty? (2018) (1)
- Clarifying misunderstandings and misinterpretations about proton pump inhibitor-responsive oesophageal eosinophilia (2016) (1)
- S1864 The Utility of Specific Symptoms and Endoscopic Features As Predictors of Eosinophilic Esophagitis (EoE) in Adults (2009) (1)
- Esophageal Dilation Demonstrates That the Majority of Esophageal Strictures Are Located in the Distal Esophagus in Adults With Eosinophilic Esophagitis (2018) (1)
- S1072 The Role of Permeability, Inflammation and Proliferation Genes in Adults With Eosinophilic Esophagitis and Their Alteration in Response to Dietary Therapy (2010) (1)
- Low Prevalence of Extraesophageal Histopathology in Eosinophilic Esophagitis (EoE) in Adults (2011) (1)
- 873 Mechanical Properties of the Esophageal Body in Patients With Eosinophilic Esophagitis (EoE): A Pilot Study Using the Functional Luminal Imaging Probe (Endoflip®) (2010) (1)
- "Imaging Findings of Eosinophilic Gastrointestinal Diseases in Adults". (2022) (1)
- Manometric, Endoscopic and Histopathologic Correlates of Diffuse Esophageal Spasm Secondary to Eosinophilic Esophagitis: Reversal with Corticosteroids (2006) (1)
- 1247 Development of a Patient Reported Outcome (PRO) Questionnaire to Assess the Symptoms of Eosinophilic Gastritis and Gastroenteritis (EG/EGE-SQ©) (2019) (1)
- Esophageal Eosinophilia and Wall Distensibility in Eosinophilic Esophagitis (EoE) Before and After Treatment: Preliminary Outcomes (2011) (1)
- Su1839 Endoscopically Identified Esophageal Features of Remodeling Correlate With Distensibility Assessed by Functional Lumen Imaging Probe (FLIP) in Eosinophilic Esophagitis (EoE) (2013) (1)
- Mo1187 DILATION REDUCES POSITIVE CORRELATION BETWEEN SYMPTOMS AND HISTOLOGIC FINDINGS IN ADULTS WITH EOSINOPHILIC ESOPHAGITIS (2020) (1)
- Monitoring patients with eosinophilic esophagitis in routine clinical practice - International Expert Recommendations. (2022) (1)
- Mo1850 Importance of Endoscopically Identified, Esophageal Features for Clinical Outcomes in Adults With Eosinophilic Esophagitis (2014) (1)
- Effect of PPI Therapy on Symptom Association Using Four-Day Bravo pH Recordings Combining 48 Hour Periods Off and on PPI: 86 (2006) (1)
- Mo1861 Development of a Symptom-Based Activity Index for Eosinophilic Esophagitis (2014) (1)
- S1983 Narrow Band Imaging May Improve the Sensitivity of Endoscopy for Diagnosing Eosinophilic Esophagitis (2008) (1)
- Esterification promotes the intracellular accumulation of roxadustat, an activator of hypoxia-inducible factors, to extend its effective duration. (2022) (1)
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY RPC4046 IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (2018) (1)
- Sustained Remission Following Six Food Elimination Diet (SFED) and Reintroduction Among Adults with EOE (2017) (1)
- Quality Indicators for the Diagnosis and Management of Eosinophilic Esophagitis. (2023) (1)
- Su1838 Esophageal Compliance Parameters Assessed With the Functional Lumen Imaging Probe (FLIP) Among Eosinophilic Esophagitis (EoE) Phenotypes (2013) (1)
- Cytomegalovirus Infection Associated with Esophagitis and Esophageal Stricture after Liver Transplantation: 549 (2007) (1)
- Mo1184 Pain With Swallowing is a Frequent and Under-Appreciated Symptom in Eosinophilic Esophagitis: Analysis From a Multicenter Randomized Placebo-Controlled Trial (2016) (1)
- S1973 Differences in Demographic and Clinical Characteristics of Eosinophilic Esophagitis in Urban and Rural U.S. Populations (2008) (1)
- Gastrointestinal and Liver Disease, Second Edition (2006) (1)
- Blockade of the interaction between BMP9 and endoglin on erythroid progenitors promotes erythropoiesis in mice (2021) (1)
- Sa1125 - New Insights Into the Pathophysiology of Eosinophilic Gastritis/Gastroenteritis in Adults: Improvement with Both Dietary and Medical Therapy (2018) (1)
- Clinical Guidance for the Use of Dupilumab in Eosinophilic Esophagitis: A Yardstick. (2022) (1)
- Assessing Adherence and Barriers to Long Term Dietary Elimination Therapy in Patients with Eosinophilic Esophagitis (EOE) (2017) (1)
- Gastrointestinal manifestations of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) (2001) (1)
- Heterozygous variants in GATA2 contribute to DCML deficiency in mice by disrupting tandem protein binding (2022) (1)
- Mo1852 Quality of Life Considerations in Adult Patients With Eosinophilic Esophagitis (2014) (1)
- UpToDate Motility/Physiology Guidelines (2007), Website reviewwww.uptodate.com, . (2008) (1)
- S1855 Monotherapy of Stenosing Eosinophilic Esophagitis with Dilation: the Patient's View of Efficacy and Tolerability (2009) (1)
- AJG-21-0760 413..423 (0)
- 165 – Development of the Eosinophilic Gastritis Molecular Diagnostic Panel (2019) (0)
- SWISS SOCIETY OF GASTROENTEROLOGY (SGG-SSG) SWISS VISCERAL SURGEONS (SGVC-SSCV) SWISS ASSOCIATION FOR THE STUDY OF THE LIVER (SASL) SWISS SOCIETY OF ENDOSCOPY NURSES AND ASSOCIATES (SVEP-ASPE) ANNUAL MEETING 2022 (2022) (0)
- Effectiveness of endoscopic dilation for dysphagia from cricopharyngeal bars (2003) (0)
- Su1123 Etiologies of Dysphagia Over the Past Decade - Emergence of Eosinophilic Esophagitis (2012) (0)
- THE EOE ROLLER (2014) (0)
- ALIMENTARY TRACT Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis (2021) (0)
- Dysphagia Days as a Clinical Marker of EoE Treatment Response in Steroid-Refractory Patients (2022) (0)
- S354 Using FLIP Panometry to Characterize Contractile Response Patterns in Patients With Eosinophilic Esophagitis (2021) (0)
- Eosinophilic Esophagitis: Treatment Approach in Adults (2012) (0)
- 230. ENDOSCOPIC REFERENCE SCORE REMODELING SUBSCORE AND ESOPHAGEAL EOSINOPHIL COUNT DO NOT CORRELATE IN PLACEBO-TREATED EOSINOPHILIC ESOPHAGITIS PATIENTS FROM DUPILUMAB STUDIES (2022) (0)
- Fr179 CHARACTERISTICS OF EOSINOPHILIC ESOPHAGITIS IN A DIVERSE COHORT OF PEDIATRIC AND ADULT PATIENTS: A MULTI-SITE STUDY (2021) (0)
- 989: DUPILUMAB IMPROVES HISTOLOGIC AND CLINICAL ASPECTS OF DISEASE IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS AT WEEK 24: RESULTS FROM PART B OF THE 3-PART LIBERTY EOE TREET STUDY (2022) (0)
- S1080 The Relationship Between Symptom Response, Esophageal Eosinophilia and Wall Distensibility in Eosinophilic Esophagitis – A Pilot Study Following Proton Pump Inhibitor Therapy (2010) (0)
- Treatment of complete heart block with inhaled beta-agonists. (1992) (0)
- Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial. (2021) (0)
- 1 year follow up of Laparoscopic Heller myotomy in achalasia (2000) (0)
- Efficacy And Safety Of Budesonide Oral Suspension In A Pediatric Population: Pooled Data From A Phase 2 And Phase 3 Trial In Patients With Eosinophilic Esophagitis (2021) (0)
- 226 FOOD-INDUCED IMMEDIATE RESPONSE IN THE ESOPHAGUS – A BURNING FIRE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (2020) (0)
- S1975 Distinct Morphologic Features, Classification Consideration and Clinical Correlation in a Large Cohort of Eosinophilic Esophagitis: A Single Center Study of 270 Adults (2008) (0)
- Eosinophilic esophagitis. Preface. (2015) (0)
- Su1167: THE ASSOCIATION BETWEEN HISTOLOGIC ABNORMALITIES AND HEALTH RELATED QUALITY OF LIFE IN PEDIATRIC PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (2022) (0)
- The Minimally Invasive 1-Hr Esophageal String Test (EST) Monitors Changes in Mucosal Inflammation in Pediatric and Adult Eosinophilic Esophagitis Patients During Treatment (2022) (0)
- Increased esophageal complicance in patients with achalasia (2001) (0)
- Mo1848 Development of an Endoscopy-and Histology-Based Activity Index for Eosinophilic Esophagitis (2014) (0)
- 876 Esophageal Distensibility As a Measure of Disease Severity in Eosinophilic Esophagitis (2013) (0)
- Esophageal Epithelium and Lamina Propria are Unevenly Involved in Eosinophilic Esophagitis. (2023) (0)
- Therapeutic options for eosinophilic esophagitis (2010) (0)
- Mucosal Microbiota Associated With Eosinophilic Esophagitis and Eosinophilic Gastritis (2022) (0)
- S353 Time to Clinically Meaningful Improvement in Dysphagia Frequency in Adults with Eosinophilic Esophagitis: A Post-Hoc Analysis From a Phase 2b Trial of APT-1011, a Fluticasone Propionate Oral Disintegrating Tablet (2021) (0)
- Social Impacts on Health Related Quality of Life in Eosinophilic Gastritis and Gastroenteritis (EGE) (2017) (0)
- Role of Antigen Presenting Cells in the Pathogenesis of Adult Eosinophilic Esophagitis - A Single Institutional Study of 285 Patients (2009) (0)
- Su1173: EFFECT OF PRIOR ESOPHAGEAL DILATION ON HISTOLOGIC, SYMPTOM AND ENDOSCOPIC OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS FROM A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION (2022) (0)
- Eosinophilic Esophagitis: A Clinico-Pathological Disease? (2014) (0)
- SAT-116 A CELL LINE DERIVED FROM RENAL ERYTHROPOIETIN-PRODUCING CELLS PROVES THEIR MYOFIBROBLAST-TRANSFORMATION PROPERTY (2019) (0)
- 621 PL02.05 LONG-TERM TREATMENT OF PATIENTS WITH EOSINOPHILIC GASTRITIS AND/OR EOSINOPHILIC DUODENITIS WITH LIRENTELIMAB, A MONOCLONAL ANTIBODY AGAINST SIGLEC-8 (2021) (0)
- Duodenal Eosinophilia in Eosinophilic Esophagitis: 2 (2009) (0)
- Mo1185 Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders (EGID) (2016) (0)
- Sa1111 - Markers of Esophageal Epithelial-Mesenchymal Transition (Emt) are Significantly Reduced in Active Eosinophilic Esophagitis Following 16 Weeks of Treatment with Rpc4046, an Anti-Interleukin-13 Monoclonal Antibody (2018) (0)
- 228 INTERIM RESULTS OF AN OPEN-LABEL EXTENSION STUDY OF ANTOLIMAB, AN ANTI-SIGLEC-8 ANTIBODY, FOR THE TREATMENT OF PATIENTS WITH EOSINOPHILIC GASTRITIS AND/OR EOSINOPHILIC ENTERITIS (2020) (0)
- Editorial: fluticasone propionate orally disintegrating tablets—interesting concept but is it going anywhere? Authors’ reply (2020) (0)
- Eosinophilic esophagitis. (2014) (0)
- Treatment of complete heart block with inhaled β-agonists (1992) (0)
- Su1179: REVIEW OF MANAGEMENT OF ESOPHAGEAL FOOD IMPACTIONS AT A TERTIARY CARE ACADEMIC CENTER BEFORE AND AFTER BEST PRACTICE IMPLEMENTATION (2022) (0)
- Su1840 Development and Field Testing of a Novel Patient Reported Outcome Measure of Dysphagia in Patients With Eosinophilic Esophagitis: The Dysphagia Symptom Questionnaire (2013) (0)
- Biopsy is Necessary for Follow-up of EoE (2014) (0)
- Pressure and high frequency intraluminal ultrasonography (HFIUS) morphology of Nissen fundoplication (FP) (2003) (0)
- Treatment of complete heart block with inhaled β-agonists (1992) (0)
- Su1156 Severity of Endoscopically Detected Esophageal Inflammatory and Fibrostenotic Features Correlates With Degree of Esophageal Eosinophilia in Adults With Eosinophilic Esophagitis (2012) (0)
- Reply (2021) (0)
- Mo1186 Caregiver-Assessed EoE Activity in Children Between 3-9 Years of Age Poorly Correlates With Physician Global Assessment, Endoscopic or Histologic Activity (2016) (0)
- Eosinophilic gastrointestinal diseases—clinically diverse and histopathologically confounding (2012) (0)
- Nonvariceal Esophageal Bleeding (2003) (0)
- S446 Results from KRYPTOS, a Phase 2/3 Study of Lirentelimab (AK002) in Adults and Adolescents With EoE (2022) (0)
- S458 Patient-Reported Symptom Improvement Following Treatment With APT-1011 in Patients with Eosinophilic Esophagitis as Measured by the PROSE: Results from FLUTE, A Phase 2b Clinical Trial (2021) (0)
- 970 Assessing Symptomatic Dysphagia Using the Dysphagia Stress Test (2013) (0)
- Predictive Validity of the Esophageal Symptom Questionnaire (ESQ) for the Absence of Patient-Reported Remission in Adult Eosinophilic Esophagitis: Preliminary Findings (2011) (0)
- AGA Gastroenterology Training Exam (GTE): a progress report. (2012) (0)
- Dysphagia Days as an Assessment of Clinical Treatment Outcome in Eosinophilic Esophagitis (2022) (0)
- Nrf2 contributes to the weight gain of mice during space travel (2020) (0)
- Characteristics of cricopharyngeal bar defined with high frequency intraluminal ultrasonography(HFIUS) and manometry (2003) (0)
- Laparoscopic Heller myotomy (lap Heller) in achalasia: A syndrome of several physiologic, neurohistologic and functional variants (2000) (0)
- Dysphagia: Interactions with Reflux Disease. (2009) (0)
- The evolving role of the wireless pH capsule in evaluation of patients with GERD (2007) (0)
- Tu1121 How Do Gastroenterologists Assess Overall Activity of Eosinophilic Esophagitis (2015) (0)
- Tu1117 The Dysphagia Symptom Questionnaire Is Responsive and Valid for Measuring Patient-Reported Outcomes in Eosinophilic Esophagitis: Analysis From a Multicenter Randomized Placebo Controlled Trial (2015) (0)
- Prevalence and radiologic features of the lower esophageal muscular ring (2000) (0)
- Mo1133 – High Patient-Reported Disease Burden for Eosinophilic Gastrointestinal Disorders (2019) (0)
- 392 Baseline Characterization of Patients With Eosinophilic Esophagitis (EoE) Using the EoE Histology Scoring System and Correlations With Endoscopic and Symptom Outcomes: Analyses From a Randomized, Placebo-Controlled Trial (2019) (0)
- Mo1228 DUPILUMAB NORMALIZES THE EOSINOPHILIC ESOPHAGITIS DISEASE TRANSCRIPTOME IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (2020) (0)
- Foregut Manifestations of Systemic Sclerosis (2011) (0)
- Foregut Manifestations of Systemic Sclerosis (2011) (0)
- Upper Gastrointestinal Tract (2012) (0)
- 2 Nonvariceal Esophageal Bleeding (2017) (0)
- S381 Esophageal Eosinophil Count Does Not Correlate With the Endoscopic Reference Score Remodeling Subscore in Placebo-Treated Eosinophilic Esophagitis Patients in the Phase 2 Proof-of-Concept and Phase 3 TREET Studies (2021) (0)
- 313 - Both Fibrotic and Inflammatory Endoscopic Alterations Contribute to Symptom Severity in Adults with Eosinophilic Esophagitis (2018) (0)
- S382 Long-Term Safety of Budesonide Oral Suspension for Eosinophilic Esophagitis: An Integrated Safety Analysis of Phase 1–3 Clinical Trial Data (2021) (0)
- Dysphagia: Interactions with Gastroesophageal Reflux Disease. (2009) (0)
- S0435 Determination of the Eosinophilic Esophagitis Endoscopic Reference Score Associated With Histologic Response to Therapy: Analysis From a Phase 3 Placebo-Controlled Trial of Budesonide Oral Suspension (2020) (0)
- Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice. (2023) (0)
- Su1854 Inter-Rater Agreement of Functional Luminal Imaging Probe (FLIP) Topographic Measurements for Eosinophilic Esophagitis (2013) (0)
- Role of Treating GERD in patients with Eosinophilic Esophagitis. (2012) (0)
- Low Prevalence of Extraesophageal Pathology in Patients With Eosinophilic Esophagitis: 372 (2017) (0)
- Role of Treating GERD in patients with Eosinophilic Esophagitis. (2012) (0)
- Su1136 Fibrostenotic Complications in Adults With Eosinophilic Esophagitis (2012) (0)
- Mo1851 The Use of Esophageal Brushings to Detect Esophageal Eosinophilia in Patients With Eosinophilic Esophagitis (2014) (0)
- 278 PRIMARY RESULTS OF A PHASE 1 MULTICENTER OPEN-LABEL STUDY OF ANTOLIMAB, AN ANTI-SIGLEC-8 ANTIBODY, FOR THE TREATMENT OF PATIENTS WITH CHRONIC GASTROINTESTINAL SYMPTOMS AND ELEVATED GASTRIC AND/OR DUODENAL MAST CELLS (2020) (0)
- Attenuation of Endoscopic Inflammatory and Stenotic Features in Patients with Co-existing Eosinophilic Esophagitis and Inflammatory Bowel Disease: 742 (2016) (0)
- S1421 Safety and Efficacy of Long-Term Treatment With Lirentelimab, A Monoclonal Antibody Against Siglec-8, in Patients With Eosinophilic Gastritis and/or Duodenitis (2021) (0)
- Squamous cell carcinoma complicating chronic ulcerative colitis. (2012) (0)
- Mo1179 OUTCOMES OF THE SIX FOOD ELIMINATION DIET AND FOOD REINTRODUCTION IN A LARGE COHORT OF ADULTS WITH EOSINOPHILIC ESOPHAGITIS (2020) (0)
- 728 Dilation in Eosinophilic Esophagitis: Safety, Effectiveness and Impact On Mucosal Inflammation (2008) (0)
- S1431 Similar Efficacy of Lirentelimab in Patients With New vs Prior Diagnoses of Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial (2021) (0)
- Reviewer Recognition 2012 (2013) (0)
- AJG-21-0877 264..271 (0)
- S449 Lirentelimab (AK002) Safety and Efficacy in Patients With Higher Eosinophil Thresholds: Supplementary Analysis of Phase 2/3 EoE KRYPTOS Trial (2022) (0)
- 115 Predicting Endoscopic and Histologic Remission in Adult Patients With Eosinophilic Esophagitis Using the EEsAI PRO Score (2015) (0)
- Su1001 CLINICAL CHARACTERISTICS AND DISEASE FEATURES FROM A MULTICENTER LONGITUDINAL COHORT OF EOSINOPHILIC GASTROINTESTINAL DISORDERS MAY INFORM FUTURE STUDIES (2020) (0)
- Contributors (2019) (0)
- Responsiveness to Both Empiric Elimination Diet and Proton Pump Inhibitor Therapy in 5 Adults With Typical Features of Eosinophilic Esophagitis: 35 (2014) (0)
- 879 The Esophageal String Test (EST) Quantifies Luminal Eosinophil and Chemokine Biomarkers Reflective of Esophageal Inflammation in Adults With Eosinophilic Esophagitis (EoE) (2013) (0)
- Automated deviation and modoling of the pressure-geometry relationship of esophageal body in impedance planimetry studies (2014) (0)
- Esophageal motor disorders (1997) (0)
- Treating Complications of EoE-Fibrosis (2016) (0)
- Treatment of Eosinophilic Esophagitis: Is there any science in what we do? (2010) (0)
- B cell development is influenced by expression of Gata1 (2017) (0)
- Acknowledgement of Reviewers 2013 (2014) (0)
- 867a: CLINICAL AND HISTOLOGICAL IMPROVEMENTS WITH WEEKLY DUPILUMAB TREATMENT IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS AT WEEK 24: WEEKLY AND EVERY 2 WEEKS’ RESULTS FROM PART B OF THE 3-PART LIBERTY EOE TREET STUDY (2022) (0)
- T1999 Premature Capsule Detachment Limits Utility of Wireless pH Monitoring in Patients with Eosinophilic Esophagitis (2008) (0)
- Detection of Hypoxia-Inducible Gene Manipulation. (2007) (0)
- Title Evaluation of Esophageal Motility Utilizing the Functional LumenImaging Probe (2016) (0)
- Isolation and Characterization of Renal Erythropoietin-Producing Cells: Contribution of HIF3α In Vivo. (2010) (0)
- Measuring esophageal compliance using functional lumen imaging probe to assess remodeling in eosinophilic esophagitis (2023) (0)
- 957 Development and Validation of an Endoscopy-Based Activity Index for Adults With Eosinophilic Esophagitis (2016) (0)
- Fr174 TIME TO FIRST DYSPHAGIA SYMPTOM RESPONSE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS FROM A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION (2021) (0)
- An Overview of Dietary Therapies for the Treatment of Eosinophilic Esophagitis. (2017) (0)
- Efficacy of RPC4046, an Anti‐Interleukin‐13 Monoclonal Antibody, in Patients With Active Eosinophilic Esophagitis: Analysis of the Steroid‐Refractory Subgroup From the HEROES Study: 934 (2019) (0)
- Editorial: cooking up something new for diet therapy of eosinophilic oesophagitis (2022) (0)
- Fr176 ENDOSCOPIC APPEARANCE DOES NOT PREDICT THE PRESENCE OF HISTOLOGIC EOSINOPHILIC GASTRITIS AMONG SYMPTOMATIC ADULTS, INDICATING THAT COLLECTION AND EVALUATION OF BIOPSIES SHOULD OCCUR REGARDLESS OF ENDOSCOPIC APPEARANCE: ANALYSIS FROM A RANDOMIZED TRIAL (2021) (0)
- 990: EFFECT OF RANDOMIZED WITHDRAWAL OF BUDESONIDE ORAL SUSPENSION ON EFFICACY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS OF HISTOLOGIC, SYMPTOM AND ENDOSCOPIC OUTCOMES (2022) (0)
- 818 – Cytokine Expression Illustrates Heterogeneity of Active Eosinophilic Esophagitis in a Large Multi-Site Cohort (2019) (0)
- The Prevalence of Eosinophilic Esophagitis in Patients Presenting with Food Impactions: A Single Center Experience of 132 Patients (2006) (0)
- S1859 Histologic Diagnosis of Eosinophilic Esophagitis: Mean Eosinophil Count But Not Peak Eosinophil Count Is Significantly Correlated with Histologic Features Demonstrating Chronic Inflammation (2009) (0)
- Su1871 Prevalence of Esophageal Squamous Cell Papilloma in Eosinophilic Esophagitis: Incidental Finding or Disease Related Consequence? (2013) (0)
- Su1196: EFFECT OF TIME SINCE DIAGNOSIS ON EFFICACY OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POOLED DATA FROM A PHASE 2 AND A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION (2022) (0)
- Su1174: CORRELATIONS OF ENDOSCOPIC REFERENCE SCORE AND DISTENSIBILITY PLATEAU IN ADULT PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS (2022) (0)
- Authors' response. (2018) (0)
- Longitudinal Association of Parent and Child Patient Reported Outcomes in Eosinophilic Esophagitis in a Multicenter Cohort (2022) (0)
- ALIMENTARY TRACT Esophageal Distensibility as a Measure of Disease Severity in Patients With Eosinophilic Esophagitis (2013) (0)
- Prevalence of Esophageal Squamous Cell Papilloma in Eosinophilic Esophagitis: Incidental Finding or Disease Related Consequence?: 94 (2012) (0)
- Mo1182 AN EPISODE-BASED, PATIENT-REPORTED OUTCOME MEASURE OF DYSPHAGIA ACCURATELY CAPTURES RESPONSE TO TREATMENT WITH APT-1011 IN A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CLINICAL TRIAL IN ADULTS WITH EOSINOPHILIC ESOPHAGITIS (2020) (0)
- 619 HIGH DISCOVERY RATE OF GASTRODUODENAL EOSINOPHILIA BUT NOT EOSINOPHILIC ESOPHAGITIS IN PATIENTS WITH CHRONIC GASTROINTESTINAL SYMPTOMS (2021) (0)
- Mo1127 – Mast Cells in Addition to Eosinophils are Markedly Elevated At Baseline in Patients with Eosinophilic Gastritis And/Or Gastroenteritis (2019) (0)
- Contributions From Gastroenterology: Acid Peptic Disorders, Barrett's Esophagus and Eosinophilic Esophagitis. (2018) (0)
- S0404 Improved Histopathologic Features in Patients With Eosinophilic Esophagitis: Results and Analyses From a Phase 3, Randomized, Placebo-Controlled Trial of Budesonide Oral Suspension (2020) (0)
- [Identification of erythropoietin producing cells and erythropoietin gene regulation]. (2014) (0)
- Markers of Esophageal Epithelial‐Mesenchymal Transition Are Significantly Reduced in Active Eosinophilic Esophagitis Following 16 Weeks of Treatment With RPC4046, an Anti‐Interleukin‐13 Monoclonal Antibody: 406 (2019) (0)
- Fr191 EOSINOPHILIC GASTRITIS AND EOSINOPHILIC DUODENITIS EXHIBIT A SIMILAR CLINICAL PRESENTATION, UNDERSCORING THE NEED FOR COLLECTION OF MULTIPLE BIOPSIES FROM BOTH THE STOMACH AND DUODENUM TO EVALUATE FOR TISSUE EOSINOPHILIA: ANALYSIS FROM A RANDOMIZED TRIAL (2021) (0)
- Fr171 LOSS OF HISTOLOGIC, SYMPTOM AND ENDOSCOPIC EFFICACY FOLLOWING TREATMENT WITHDRAWAL IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: A PHASE 3, RANDOMIZED WITHDRAWAL STUDY OF BUDESONIDE ORAL SUSPENSION (2021) (0)
- S387 Dupilumab Improves Clinical, Symptomatic, Histologic, and Endoscopic Aspects of EoE up to 24 Weeks: Pooled Results From Parts A and B of Phase 3 LIBERTY-EoE-TREET (2022) (0)
- Su1090 Development of the Dysphagia Stress Test: A Novel Tool for Assessment of Esophageal Dysphagia (2016) (0)
- Changes in Mast Cell Gene Expression in Adults with Eosinophilic Esophagitis and their Responsiveness to Therapy (2010) (0)
- 227 BUDESONIDE ORAL SUSPENSION (BOS) IMPROVES ENDOSCOPIC ACTIVITY IN ADOLESCENTS AND ADULTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS AND CORRELATION ANALYSIS FROM A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL (2020) (0)
- DDW 2018: Activities and Interests of the AGA Council (2018) (0)
- 1244 Symptomatic Patients Suspected of Eosinophilic Gastritis and/or Enteritis Have Elevated Mucosal Mast Cell Counts Without Eosinophilia: A New Diagnostic Entity? (2019) (0)
- Su1120 Relationship of Quality of Life With Symptom Severity, Endoscopy, and Histology in Adults With Eosinophilic Esophagitis (2015) (0)
- Tu1031 Natural Language Processing of Electronic Health Records Accurately Identifies Right Colon Hyperplastic Polyps for Potential Surveillance Reclassification (2014) (0)
- Budesonide Oral Suspension Improves Histologic Features In Patients With Eosinophilic Esophagitis: Results From A Phase 3, Randomized, Double-blind, Placebo-Controlled Trial (2020) (0)
- Deaths after living related liver transplantation [1] (multiple letters) (2000) (0)
- 359 – Eosinophilic Esophagitis-Like Disease with Lack of Significant Esophageal Eosinophilia: Description of a New Disease Entity (2019) (0)
- Sa1182: LONGITUDINAL FOLLOW-UP OF PATIENTS WITH EOSINOPHILIC ESOPHAGITIS VARIANTS AND THEIR POTENTIAL TO PROGRESS TO EOE: A CLINICAL, HISTOLOGICAL AND MOLECULAR MULTI-CENTER ANALYSIS (2022) (0)
- Preliminary Validation of a Measure of Adult Eosinophilic Esophagitis Patient Reported Outcomes (2011) (0)
- Chapter Fifteen – Management of achalasia (2006) (0)
- Rescue of Erythropoietin-Deficient Mice From Anemia by Complementation with BAC Transgene. (2009) (0)
- Esterification Increases the Cell Permeability of Roxadustat, an Activator of Hypoxia-Inducible Factors, to Extend its Effective Duration (2021) (0)
- A connection found between mast cells and pain in eosinophilic esophagitis (2022) (0)
- Dupilumab suppresses type 2 biomarkers of inflammation in patients with eosinophilic esophagitis: from Part B of LIBERTY-EoE-TREET (2023) (0)
- Fr175 TREATMENT OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS WITH OR WITHOUT CONCOMITANT THERAPIES: POST HOC ANALYSIS FROM A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION (2021) (0)
- Maintenance topical steroid therapy in eosinophilic esophagitis: Not so hard to swallow any more? (2020) (0)
- Distinct manometric features of symptomatic lower esophageal muscular rings (2000) (0)
- Chapter 9. Esophageal Disorders (2008) (0)
- AJG-21-1701 272..279 (0)
- Clinical correlation of esophageal and gastric pathologic changes in achalasia (2003) (0)
- Pro/Con: Frequent Endoscopy or Monitor Symptoms (Frequent Endoscopy) (2018) (0)
- Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis – new data bring new questions. Authors' reply (2023) (0)
- Sa1112 - Endoscopic Features are Significantly Associated with Histologic Measures of Disease Activity in Patients with Active Eosinophilic Esophagitis: A Post HOC Analysis of a Randomized, Placebo-Controlled, Phase 2 Dupilumab Trial (2018) (0)
- Su1186: QUALITY INDICATORS FOR THE DIAGNOSIS AND MANAGEMENT OF EOSINOPHILIC ESOPHAGITIS: RESULTS FROM A DELPHI PROCESS (2022) (0)
- Fr172 LOW RATES OF GLUCOCORTICOID-RELATED ADVERSE EFFECTS WITH LONG-TERM TREATMENT OF EOSINOPHILIC ESOPHAGITIS WITH FLUTICASONE PROPIONATE ORALLY DISINTEGRATING TABLET (APT-1011): RESULTS FROM 52 WEEKS OF EXPOSURE IN A PHASE 2B TRIAL. (2021) (0)
- S1405 Endoscopy and Systematic Biopsy of Patients With Moderate-Severe Unexplained Gastrointestinal Symptoms Compared With Healthy Controls: High Discovery Rate of Eosinophilic Gastritis and/or Eosinophilic Duodenitis (2021) (0)
- A patient with dysphagia to solids and liquids (2006) (0)
- Fr173 OPTIMIZATION OF EOSINOPHILIC GASTRITIS/DUODENITIS DETECTION REQUIRES EVALUATION OF MULTIPLE HIGH-POWERED FIELDS IN EACH OF 8 GASTRIC AND 4 DUODENAL BIOPSIES: ANALYSIS FROM A RANDOMIZED TRIAL (2021) (0)
- P400 BUDESONIDE ORAL SUSPENSION TREATMENT IMPROVES DYSPHAGIA SYMPTOMS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ikuo Hirano?
Ikuo Hirano is affiliated with the following schools:
